LyondellBasell's 49% Rally Bought the Rebound-Now Investors Need Proof

LyondellBasell's rally reflected a better setup, not a fully proven turn

LyondellBasell's 49.5% increase in the last 90 days looked and felt like a relief rally. The setup was straightforward: a firmer global cost backdrop, a company management said could capture upside from its lower-cost base, and a market eager to reward any sign that the downturn was losing steam. That can move a stock quickly in a beaten-down industry, but it is not the same as proving the business has turned.

The quarter improved the bull case

The latest results did make the bullish case easier to see. LyondellBasell posted second-quarter 2026 net income of $0.6 billion, or $1.71 diluted EPS, after a much weaker first quarter that showed just $0.38 diluted EPS. That kind of jump gives investors a reason to think pricing and operating leverage are starting to show up in the numbers.

Why the debate has not ended

The caution case is still real. The board recalibrated the dividend earlier this year, and management framed the current environment as one of the longest downturns in the industry. Recent insider activity also showed a net sell-off over the past 90 days, including more than $25 million in proposed sales by a 10% stockholder affiliate.

That is why the next report matters. Investors do not need another hopeful setup; they need evidence that this quarter was the start of a more durable recovery rather than a good quarter inside a difficult cycle.

Q2 margins and portfolio changes improved the operating picture

EBITDA is the clearest sign the business improved

In chemicals, EBITDA is often the cleaner scoreboard because it better reflects how assets perform when prices improve and utilization rises. By that measure, LyondellBasell's second quarter was meaningfully better, with $2.1 billion EBITDA excluding identified items and a 23% EBITDA margin. That suggests price was doing more of the work as conditions improved.

The operating logic is simple. When demand warms and higher-cost supply stays muted, each extra dollar of price falls into a business with relatively fixed costs. That is where a lower-cost base matters. LyondellBasell also said it strengthened the portfolio through the divestiture of select European assets, while fixed-cost reductions and lower capital spending should help more of that pricing flow through.

The improvement was broad, even if the recovery is not fully proven

The stronger result was not limited to one part of the business. O&P Americas remained the main engine, with EBITDA of $1.3 billion, about four times higher than a year earlier. I&D EBITDA also increased sequentially, and other operating segments showed improvement as well. That does not mean every business line is healed, but it does suggest the upturn was broad enough to matter.

Trailing profitability still shows how far the company has to go

A strong quarter is not the same as a healed income statement. As of the latest quarter, trailing twelve-month net income was negative and the net margin was -1.13%. In other words, the company is building back, but the full cycle damage has not yet been erased.

That makes balance-sheet discipline essential. LyondellBasell ended the quarter with $2.6 billion in cash and $7.1 billion of available liquidity, generated $752 million of operating cash flow, and spent just $270 million on capital investments. If that posture holds, the company is better placed to withstand another rough patch while the recovery strengthens.

Investors should treat LYB as a cyclical recovery to monitor, not a finished comeback

After a sharp rebound and a better-than-feared quarter, the question is no longer whether LyondellBasell is interesting. It is. The question is how much faith to give it before the next proof point. The most reasonable stance is to respect the recovery signal, but still demand evidence before paying up for it.

The dividend cut shows caution, not collapse

The board's decision to recalibrate the dividend with a $0.68 per share reduction shows that markets were still too weak for a full return to normal. At the same time, management said the cut was meant to better position the company for the recovery and reiterated a commitment to return 70% of free cash flow through the cycle. That is the commitment investors should watch going forward.

The next proof points are cash, discipline, and follow-through

LyondellBasell already has a stronger starting point with $2.6 billion in cash, $7.1 billion of available liquidity, $752 million of operating cash flow, and only $270 million of capital investments in the quarter. The next report needs to show that this can translate into sustained cash generation and continued discipline, not just one strong quarter.

What would weaken the setup

The thesis weakens if cash generation fades, spending becomes less disciplined, or the dividend cut starts to look like a sign of deeper strain rather than temporary caution. It also becomes riskier if the stock keeps running before those operating proof points are confirmed. For now, the more measured approach is to treat LYB as a monitored cyclical position and add only if the results keep improving.